A novel, sensitive dual-indicator cell line for detection and quantification of inducible, replication-competent latent HIV-1 from reservoir cells

Change log
Gludish, David W. 
Jarvis, Isobel 
Boliar, Saikat 
Wills, Mark R. 

Abstract: Understanding the mechanisms involved in HIV infection and latency, and development of a cure, rely on the availability of sensitive research tools such as indicator cells, which allow rigorous quantification of viral activity. Here we describe the construction and validation of a novel dual-indicator cell line, Sup-GGR, which offers two different readouts to quantify viral replication. A construct expressing both Gaussia luciferase and hrGFP in a Tat- and Rev-dependent manner was engineered into SupT1-CCR5 to create Sup-GGR cells. This cell line supports the replication of both X4 and R5-tropic HIV as efficiently as its parental cell line, SupT1-CCR5, and allows repeated sampling without the need to terminate the culture. Sup-GGR demonstrates comparable sensitivity and similar kinetics in virus outgrowth assays (VOA) to SupT1-CCR5 using clinical samples. However the Gaussia luciferase reporter is significantly less labor-intensive and allows earlier detection of reactivated latent viruses compared to the conventional HIV p24 ELISA assay. The Sup-GGR cell line constitutes a versatile new tool for HIV research and clinical trials.


Funder: DH | National Institute for Health Research (NIHR); doi: https://doi.org/10.13039/501100000272

Funder: U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)

Article, /631/1647/2234, /631/326/596/1787, /13/31, /14/63, /13/109, /38/1, article
Journal Title
Scientific Reports
Conference Name
Journal ISSN
Volume Title
Nature Publishing Group UK
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD) (T32OD011182)
RCUK | MRC | Medical Research Foundation (MR/S009752/1)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) (AI118582, AI136097)
RCUK | Medical Research Council (MRC) (MR/N02043X/1)